In-House Round Table Part 2: The Life Sciences Perspective

July 18, 2018 10:00am

Jeffrey J. Hohenshell
Senior Patent Attorney
Medtronic (Minneapolis, MN)

Leon Lum
Intellectual Property Counsel
Novo Nordisk Inc. (Plainsboro, NJ)

Keith A. Newburry
VP, Chief Intellectual Property Counsel
Edwards Lifesciences (Irvine, CA)

Hans Sauer
Deputy General Counsel for Intellectual Property
Biotechnology Innovation Organization (Washington, D.C.)

Paul Simboli
Vice President, Intellectual Property & Asst. General Counsel
Depomed, Inc


Justin J. Oliver
Fitzpatrick, Cella, Harper & Scinto (Washington, D.C.)

Megan F. Raymond
Paul, Weiss, Rifkind, Wharton & Garrison LLP (Washington, D.C.)

Gain the perspectives of top executives from leading pharmaceutical and medical device companies who will discuss the strategies they implement when working through PTAB proceedings. Topics of discussion will include strategies for filing an IPR, analyzing the costs involved, the qualifications desired when hiring outside counsel, selecting an expert witness, working with co-defendants, and settlement strategies.